Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Gonadorelin structure

Gonadorelin

Other
Approved Research
85%
Low Risk
1/5

Dosing Protocol

Typical Dose 100 mcg
Range 50 - 200 mcg
Maintenance 100 mcg 2x daily

Pharmacokinetics

Half-Life 15 min
Onset 5 min
Peak 20 min
Duration 1.5 hrs
Bioavailability 90%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intravenous, Intramuscular
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning, Evening

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 500 mcg/mL
Stability 14 days refrigerated
Vial Sizes 1, 2 mg

Special Instructions

Pulsatile dosing maintains pituitary sensitivity. Continuous dosing causes desensitization/downregulation. Used for TRT PCT and fertility.